biomee ApS: Financial statements 2021
CVR: 29829586
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
biomee ApS (CVR 29829586) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 8,630,918 and a net result of DKK 7,786,490 compared with DKK -2,776,006 the year before. Equity in the 2021 report amounted to DKK 207,609. The solvency ratio was 17%.
- Gross Profit
- DKK 8,630,918
- Profit/Loss
- DKK 7,786,490
- Equity
- DKK 207,609
- Total Assets
- DKK 1,221,515
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 8.6 mio. | 7.8 mio. | 208 t. | - |
| 2020 | - | -461 t. | -2.8 mio. | -57.6 mio. | - |
| 2019 | - | -273 t. | -2.4 mio. | -54.8 mio. | - |
| 2018 | - | -386 t. | -2.4 mio. | -52.4 mio. | 0 |
| 2017 | - | -7.8 mio. | -4.2 mio. | -50.1 mio. | - |
Official annual report
Find more companies like biomee ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Biomee ApS has published its annual report for 2020. Gross profit came to DKK -461,055, and the net result was DKK -2,776,006.
On March 18, 2021, the company changed its name from DRUG DELIVERY SOLUTIONS ApS to biomee ApS.
About biomee ApS
biomee ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DRUG DELIVERY SOLUTIONS ApS and TOXICELL ApS. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. Equity in the 2025 report amounted to DKK 23,772,837.